These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 27888645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA, Jacobsen C, Christensen ME.
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
    [Abstract] [Full Text] [Related]

  • 3. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.
    Agache I, Doros IC, Leru PM, Bucur I, Poenaru M, Sarafoleanu C.
    Rhinology; 2018 Mar 01; 56(1):33-41. PubMed ID: 28942457
    [Abstract] [Full Text] [Related]

  • 4. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R, Nguyen DT, Kuhl HC.
    Immun Inflamm Dis; 2018 Dec 01; 6(4):456-464. PubMed ID: 30306729
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W, Meltzer EO, Amar N, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Bousquet J.
    Pediatr Allergy Immunol; 2016 Mar 01; 27(2):126-33. PubMed ID: 26928753
    [Abstract] [Full Text] [Related]

  • 6. Control of allergic rhinitis with MP-AzeFlu: a noninterventional study of a Swedish cohort.
    Stjarne P, Strand V, Theman K, Ehnhage A.
    Rhinology; 2019 Aug 01; 57(4):279-286. PubMed ID: 30938376
    [Abstract] [Full Text] [Related]

  • 7. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
    Klimek L, Price D, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, van Weissenbruch R, Pohl W, Kuhl HC, Scadding G, Mullol J.
    Int Arch Allergy Immunol; 2020 Aug 01; 181(10):754-764. PubMed ID: 32829329
    [Abstract] [Full Text] [Related]

  • 8. Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
    Bousquet J, Meltzer EO, Couroux P, Koltun A, Kopietz F, Munzel U, Kuhl HC, Nguyen DT, Salapatek AM, Price D.
    J Allergy Clin Immunol Pract; 2018 Aug 01; 6(5):1726-1732.e6. PubMed ID: 29425904
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI, Edin AS, Astafieva NG, Lopatin AS, Sidorenko IV, Ukhanova OP, Khanova FM.
    Int Arch Allergy Immunol; 2019 Aug 01; 178(3):255-263. PubMed ID: 30677766
    [Abstract] [Full Text] [Related]

  • 10. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE, Meltzer EO.
    Am J Rhinol Allergy; 2015 Aug 01; 29(4):273-82. PubMed ID: 26132312
    [Abstract] [Full Text] [Related]

  • 11. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
    Berger W, Bousquet J, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Wahn U.
    Allergy; 2016 Aug 01; 71(8):1219-22. PubMed ID: 27043452
    [Abstract] [Full Text] [Related]

  • 12. MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study.
    Klimek L, Bachert C, Stjärne P, Dollner R, Larsen P, Haahr P, Agache I, Scadding G, Price D.
    Allergy Asthma Proc; 2016 Sep 01; 37(5):376-86. PubMed ID: 27657521
    [Abstract] [Full Text] [Related]

  • 13. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G, Price D, El-Shanawany T, Ahmed S, Ray J, Sargur R, Kumar N.
    BMJ Open; 2017 Apr 24; 7(4):e014777. PubMed ID: 28442578
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis.
    Zhong Z, Xun Y, Shi X, Guan B, Wang M.
    Eur Arch Otorhinolaryngol; 2022 May 24; 279(5):2457-2464. PubMed ID: 34415405
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of nasal steroids and montelukast on olfactory functions in patients with allergic rhinitis.
    Dalgic A, Dinc ME, Ulusoy S, Dizdar D, Is A, Topak M.
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep 24; 134(4):213-216. PubMed ID: 28109729
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
    Klimek L, Demoly P, Price D.
    Expert Rev Clin Pharmacol; 2016 Sep 24; 9(5):705-14. PubMed ID: 26839083
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.